Natco Pharma (Canada) Inc.

Natco Pharma (Canada) Inc. company information, Employees & Contact Information

Natco Pharma (Canada) Inc. is the Canadian subsidiary of Natco Pharma Limited. We are a vertically integrated pharmaceutical company focused on R&D and the manufacturing of drug products. NATCO is a trusted supplier of medicines evidenced from our work with the world’s largest drug companies. NATCO prioritizes trust and reliability in our products and services – That is our Canadian commitment.

Company Details

Employees
42
Founded
-
Address
2000 Argentia Rd, Suite 200,plaza 1,canada
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Pharmaceuticals.
HQ
Mississauga, Ontario
Looking for a particular Natco Pharma (Canada) Inc. employee's phone or email?

Natco Pharma (Canada) Inc. Questions

News

Insiders At NATCO Pharma Sold ₹69m In Stock, Alluding To Potential Weakness - simplywall.st

Insiders At NATCO Pharma Sold ₹69m In Stock, Alluding To Potential Weakness simplywall.st

Natco Pharma sues Novo Nordisk in generic drug push - The Economic Times

Natco Pharma sues Novo Nordisk in generic drug push The Economic Times

Natco Pharma mulls demerger of agro business - The Hindu

Natco Pharma mulls demerger of agro business The Hindu

NATCO Pharma Shares Plummet 19% Post Q3 Results Amid Sharp Revenue and Profit Decline -Should You Buy? - Times Now

NATCO Pharma Shares Plummet 19% Post Q3 Results Amid Sharp Revenue and Profit Decline -Should You Buy? Times Now

Natco Pharma Q4 Results: Profit rises 5%, revenue up 16% YoY; warns of FY26 headwinds - CNBC TV18

Natco Pharma Q4 Results: Profit rises 5%, revenue up 16% YoY; warns of FY26 headwinds CNBC TV18

Natco Pharma shares tank 19%, near 52-week low on weak Q3 results - Business Standard

Natco Pharma shares tank 19%, near 52-week low on weak Q3 results Business Standard

U.S. FDA issues 7 observations to Natco Pharma’s formulations unit in Hyderabad - The Hindu

U.S. FDA issues 7 observations to Natco Pharma’s formulations unit in Hyderabad The Hindu

NATCO Pharma Canada arm invests over Rs 67 crore in biotech company eGenesis - Medical Dialogues

NATCO Pharma Canada arm invests over Rs 67 crore in biotech company eGenesis Medical Dialogues

Natco Pharma Canada arm invests $8 mln in eGenesis - Business Standard

Natco Pharma Canada arm invests $8 mln in eGenesis Business Standard

Natco Pharma Shares Up 3% After Settling US Patent Litigation on Generic Ozempic - Equitypandit

Natco Pharma Shares Up 3% After Settling US Patent Litigation on Generic Ozempic Equitypandit

Multiple Myeloma medicine: Natco Pharma unveils Pomalidomide under brand NAT-POMALIDOMIDE in Canada - Medical Dialogues

Multiple Myeloma medicine: Natco Pharma unveils Pomalidomide under brand NAT-POMALIDOMIDE in Canada Medical Dialogues

Natco Pharma gains 3% on $8 million investment in US biotech firm eGenesis - CNBC TV18

Natco Pharma gains 3% on $8 million investment in US biotech firm eGenesis CNBC TV18

Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20 - Medical Buyer

Natco Pharma anticipates India, Brazil, Canada markets to be revenue drivers for FY20 Medical Buyer

Natco Pharma shares gain after settlement in US patent litigation on generic Ozempic - CNBC TV18

Natco Pharma shares gain after settlement in US patent litigation on generic Ozempic CNBC TV18

Natco Pharma announces resignation of Sourav Chakraborty, Associate Vice President - Sales & Marketing,... - Medical Dialogues

Natco Pharma announces resignation of Sourav Chakraborty, Associate Vice President - Sales & Marketing,... Medical Dialogues

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis - Business Standard

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis Business Standard

Natco arm, Celgene to settle dispute on cancer drug in Canada - The Hindu

Natco arm, Celgene to settle dispute on cancer drug in Canada The Hindu

Dr Reddy's, Natco Pharma launch generic cancer drug in Canada - Business Standard

Dr Reddy's, Natco Pharma launch generic cancer drug in Canada Business Standard

Hyderabad-based Natco Pharma returns to profit in Q4 as business grows in US, Canada - CNBC TV18

Hyderabad-based Natco Pharma returns to profit in Q4 as business grows in US, Canada CNBC TV18

Eli Lilly inks pact with Natco Pharma for Covid-19 drug baricitinib - Business Standard

Eli Lilly inks pact with Natco Pharma for Covid-19 drug baricitinib Business Standard

Polycab, Natco Pharma, Bikaji Foods & Gujarat Alkalies: 4 stock picks by SMC Global - Business Today

Polycab, Natco Pharma, Bikaji Foods & Gujarat Alkalies: 4 stock picks by SMC Global Business Today

Natco Pharma bullish on India, Brazil, Canada biz for FY20 - Zee Business

Natco Pharma bullish on India, Brazil, Canada biz for FY20 Zee Business

Natco Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 - shareprice-target.com

Natco Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 shareprice-target.com

Top Natco Pharma (Canada) Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant